Melinta Therapeutics

KIMYRSA - Cost

Last Updated: April 1st, 2024

HCPCS:

J2406

HCPCS Code Descriptor:

Injection, oritavancin (kimyrsa), 10 mg

Medicare Payment Limit:

The KIMYRSA Medicare Payment Limit is $40.895

Average Sale Price:

KIMYRSA ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The KIMYRSA Medicare Co-insurance percentage is 20%. KIMYRSA's Medicare Co-insurance amount is $8.18 per HCPCS unit.

APC Code:

The Kimyrsa APC Code is: 9427

APC Payment Limit:

The APC Payment Limit for KIMYRSA is available. Login to view.

Kimyrsa Cost Information:

KIMYRSA, manufactured by Melinta Therapeutics, became effective on October 1, 2021 and is aligned to HCPCS J2406. Pricing has moderately trended upwards by around 5%. As of 2024, ASP remained slightly below WAC.

ACCESS PRICING AND MORE BY REGISTERING

Kimyrsa’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Kimyrsa’s average wholesale price (AWP) information was last updated on:
January 1, 2024